Reach your press release and disclosure targets.
Get more views with multimedia.
Track your results and refine your message.
Be the news everyone talks about.
Latest News
Today is April 10, 2021.
All times in Eastern Daylight Time.
-
Saturday WrestleMania® Sold OutTAMPA BAY, Fla.--(BUSINESS WIRE)--A sell-out of 25,675 fans attended Night One of WrestleMania at Raymond James Stadium in Tampa Bay, FL with millions more watching at home on Peacock in the U.S. a... more »
-
Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recurring Breast CancerSTAFFORD, Texas--(BUSINESS WIRE)--GLSI's Immune Response Data Shows Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recurring Breast Cancer more »
-
Le test métallurgique de Lomiko au site de La Loutre produit un grade de concentré de 97,8% de carbone et de 93,5% de récupération de graphiteMONTRÉAL--(BUSINESS WIRE)--Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) ("Lomiko" ou la "Société") a le plaisir de publier une mise à jour relative à son projet d'extraction de graphite à... more »
-
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Champignon Brands Inc. Investors – SHRMFNEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Champignon Brands Inc. (OTC:... more »
-
AHF Welcomes Biden’s Proposed 15% HUD Budget IncreaseLOS ANGELES--(BUSINESS WIRE)--AHF Welcomes Biden’s Proposed 15% HUD Budget Increase more »
-
EIG ondertekent infrastructuurovereenkomst van $ 12,4 miljard met AramcoWASHINGTON--(BUSINESS WIRE)--EIG, een toonaangevende institutionele belegger in de wereldwijde energiesector en een van 's werelds vooraanstaande investeerders in infrastructuur, heeft vandaag aang... more »
-
Voluntary Recall of Hostess® SnoBalls® Due to Undeclared AllergenLENEXA, Kan.--(BUSINESS WIRE)--Hostess Brands, LLC (“Hostess Brands”) has become aware that certain Hostess® SnoBalls® were inadvertently manufactured in the packaging for Hostess® Chocolate CupCak... more »
-
GlycoMimetics to Present at AACR 2021 Meeting on Positive Therapeutic Effects of GMI-1757 in a Pancreatic Adenocarcinoma ModelROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC) today announces that an abstract presenting the results of a recent preclinical study on the therapeutic effects of GMI-1757, a n... more »
-
Positive Findings From Phase 1b Trial of GlycoMimetics’ GMI-1359 To Be Presented at AACR 2021 MeetingROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC) today announces that a Phase 1b trial of GMI-1359, being conducted at Duke University Cancer Center, showed evidence of on-target... more »
-
Ultimovacs Presents the INITIUM Study Design as a Trial-in-Progress Poster at AACR Annual Meeting 2021OSLO, Norway--(BUSINESS WIRE)--Ultimovacs ASA ("Ultimovacs", ticker ULTI), announced that it is presenting a poster today on the trial design of its ongoing Phase II INITIUM clinical study evaluati... more »
-
Data at AACR Demonstrate Growing Clinical Utility of Guardant Health Liquid Biopsies in the Treatment and Management of Advanced CancersREDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, presents new data at the AACR Virtual Annual Meetin... more »
-
Investigational Combination of Aliqopa® (copanlisib) and rituximab Significantly Increases Progression-Free Survival in Patients with Relapsed Indolent non-Hodgkin's LymphomaWHIPPANY, N.J.--(BUSINESS WIRE)--Results from the randomized, double-blind, placebo-controlled Phase III trial CHRONOS-3 show a significant improvement in progression-free survival (PFS) with the i... more »
-
Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual MeetingHAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today presented progression-fr... more »
-
Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC PatientsBOULDER, Colo.--(BUSINESS WIRE)--Biodesix releases new data at AACR annual meeting on the use of proteomic profiling to help guide physician treatment strategies for NSCLC patients. more »
-
Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and a... more »